Cited by 90Electroconvulsive Therapy StudiesTryptophan and brain disordersStress Responses and Cortisol

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

The Immune System and Electroconvulsive Therapy for Depression

Guloksuz, Sinan, Rutten, Bart P.F., Arts, Baer, van Os, Jim, Kenis, Gunter·2014·The Journal of ECT

Abstract

BACKGROUND: Electroconvulsive therapy (ECT) remains the most effective and fast-acting treatment option for several psychiatric conditions, including treatment-resistant depression. Although ECT has been in use for 75 years, the mechanism of action is unknown. There is emerging evidence that modulation of the hypothalamic-pituitary-adrenal axis may mediate, in part, the therapeutic action of ECT. A growing body of evidence points to links between disturbances in the immune system and depression. However, the impact of ECT on immune functioning and the possible role of alterations in the immune system as a mechanism of action of ECT remain elusive. OBJECTIVES: To provide a literature overview on the effects of ECT on the immune system. METHODS: Relevant articles and abstracts in English were retrieved from PubMed/Medline using search terms related to ECT, inflammation, and immune system. The results of studies examining ECT-induced changes in immune functioning as well as the degree to which these represent possible mechanisms mediating the therapeutic action of ECT were summarized. RESULTS: Our search identified only a limited number of studies. The findings suggest that a single session of ECT induces an acute, transient immune activation, whereas repetitive ECT treatment results in long-term down-regulation of immune activation. However, inconsistency in findings and methodological issues, including sample size and lack of consideration of confounding factors affecting cytokine concentrations, precludes definitive conclusion. CONCLUSIONS: To elucidate the possible role of immunological changes mediating the effect of ECT, more prospective controlled studies with larger sample sizes are required.

Overview

Integrity signals

Registry

Crossref · 10.1097/yct.0000000000000127

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 7 references

Research works printed but not linked: 7

  1. 2003, Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis., Lancet, 361, 799, 10.1016/S0140-6736(03)12705-5 · DOI · Paper page
  2. 2014, Neurotransmitters and ECT., J ECT, 30, 116
  3. 2014, Neuroendocrine hypotheses, including pituitary-adrenal axis., J ECT, 30, 107
  4. 2014, Imaging the brain duringafter ECT: a look inside the mechanism of action., J ECT, 30, 143
  5. 2011, How does electroconvulsive therapy work Theories on its mechanism., Can J Psychiatry, 56, 13, 10.1177/070674371105600104 · DOI
  6. 1991, The macrophage theory of depression., Med Hypotheses, 35, 298, 10.1016/0306-9877(91)90272-Z · DOI · Paper page
  7. 2012, Kynurenines: from the perspective of major psychiatric disorders., FEBS J, 279, 1375, 10.1111/j.1742-4658.2012.08551.x · DOI

Cited by

Sorted by citations

See all 90

Metadata

Authors
Guloksuz, S., Rutten, B. P. F., Arts, B., van Os, J., & Kenis, G.
Affiliations
Maastricht University Medical Centre (NL)
Corresponding author
  • Rutten, Bart P.F.
  • Arts, Baer
Venue
The Journal of ECT
Published
2014-06
Volume
30
Issue
2
Pages
132-137
ISSN
1095-0680 (ISSN-L)
OpenAlex
W2060188551
Cited by
90
References
7
Citations by year
2026: 3 · 2025: 4 · 2024: 9 · 2023: 6 · 2022: 10 · 2021: 14 · 2020: 8 · 2019: 13 · 2018: 7 · 2017: 6 · 2016: 4 · 2015: 5 · 2014: 1
FWCI
4.07
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Ect (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
electroconvulsive therapy, depression, immune system, inflammation, cytokines, hypothalamic-pituitary-adrenal axis, treatment-resistant depression, mechanism of action, immune activation
MeSH terms
Depression, Electroconvulsive Therapy, Humans, Immune System

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review